1 Min Read
* Says it received a patent license (No. ZL 2013 1 0257018.5), regarding lixisenatide controlled-release microspheres and preparation method
Source text in Chinese: goo.gl/JKJvvN
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.